References
- Garami A, Ilg T. Disruption of mannose activation in Leishmania mexicana: GDP-mannose pyrophosphorylase is required for virulence, but not for viability. EMBO J.14, 3657–3666 (2001).
- Tanner KG, Landry J, Sternglanz R, Denu JM. Silent information regulator 2 family of NAD dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose. Proc. Natl Acad. Sci. USA97, 14178–14182 (2000).
- Tanny J, Moazed D. Recognition of acetylated proteins. Lessons from an ancient family of enzymes. Structure (Camb.)10, 1290–1292 (2002).
- Vergnes B, Sereno D, Cordeiro-da-Silva A et al. Targeted disruption of cytosolic SIR2 deacetylase discloses its essential role in Leishmania survival and proliferation. Gene363C, 85–96 (2005).
- Garcia-Salcedo JA, Gijon P, Nolan DP, Tebabi P, Pays E. A chromosomal SIR2 homologue with both histone NAD-dependent ADP-ribosyltransferase and deacetylase activities is involved in DNA repair in Trypanosoma brucei. EMBO J.22, 5851–5862 (2003).
- Alsford S, Kawahara T, Isamah C, Horn D. A sirtuin in the African trypanosome is involved in both DNA repair and telomeric gene silencing but is not required for antigenic variation. Mol. Microbiol.63, 724–736 (2007).
- Rameshwar U. Kadam, Kiran VM, Nilanjan R. Comparative protein modeling and surface analysis of Leishmania sirtuin: a potential target for antileishmanial drug discovery. Bioorg. Med. Chem. Lett.16, 6013–6018 (2006).
- Taibi A, Plumas-Marty B, Pessoa H, Loyens M, Capron A, Ouaissi A. Trypanosoma cruzi: immunity induced in mice and rats by trypomastigote excretory–secretory antigens and identification of peptide sequence containing a T cell epitope with protective activity. J. Immunol.151, 2676–2689 (1993).
- Ouaissi A, Guilvard E, Delneste Y et al. The Trypanosoma cruzi Tc52 released protein induces human dendritic cell maturation, signals via Toll-like receptor 2, and confers protection against lethal infection. J. Immunol.168, 6366–6374 (2002).
- Gorczynski RM. Immunization of susceptible BALB/c mice against Leishmania braziliensis. II. Use of temperature-sensitive avirulent clones of parasite for vaccination purposes. Cell. Immunol.94, 11–20 (1985).
- Kimsey PB, Theodos CM, Mitchen TK, Turco SJ, Titus RG. An avirulent lipophosphoglycan-deficient Leishmania major clone induces CD4+ T cells which protect susceptible BALB/c mice against infection with virulent L. major. Infect. Immun.61, 5205–5213 (1993).
- Alexander J, Coombs GH, Mottram JC. Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response. J. Immunol.161, 6794–6801 (1998).
- Sanchez-Burgos G, Mezquita-Vega RG, Escobedo-Ortegon J et al. Comparative evaluation of therapeutic DNA vaccines against Trypanosoma cruzi in mice. FEMS Immunol. Med. Microbiol. DOI: 10.1111/j.1574-695X.2007.00251.x (2007) (Epub ahead of print).
- Ouaissi A. Regulatory cells and immunosuppressive cytokines: parasite-derived factors induced immune polarization. J. Biomed. Biotech.2007(4), 94971 (2007).
- Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A. Interleukin 10 and the interleukin 10 receptor. Annu. Rev. Immunol.19, 683–765 (2001).
- Del Prete G. Human IL-10 is produced by both type 1 helper (Th1) and type 2 (Th2) cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol.150, 353–360 (1993).
- Belkaid Y, Blank, RB, Suffia I. Natural regulatory T cells and parasites: a common quest for host homeostasis. Immunol. Rev.212, 287–300, (2006).
- Coler RN, Goto Y, Bogatzki L, Raman V, Reed SG. Leish-111f, a recombinant polyprotein vaccine that protects against visceral leishmaniasis by the elicitation of CD4+ cells. Infect. Immun. DOI:IAI.00394-07v1 (2007) (Epub ahead of print).
- Spath GF, Lye LF, Segawa H, Sacks DL, Turco SJ, Beverley SM. Persistence without pathology in phosphoglycan-deficient Leishmania major. Science301, 1241–1243 (2003).
- Silvestre R, Cordeiro-da-Silva A, Santarem N, Vergnes B, Sereno D, Ouaissi A. SIR2-deficient L. infantum induces a defined IFN-γ/IL-10 pattern that correlates with protection. J. Immunol.179 (2007).